An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.
This report aims to provide a comprehensive presentation of the global market for Biological Vaccines Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Vaccines Adjuvants. This report contains market size and forecasts of Biological Vaccines Adjuvants in global, including the following market information:
Global Biological Vaccines Adjuvants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biological Vaccines Adjuvants Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biological Vaccines Adjuvants companies in 2022 (%)
The global Biological Vaccines Adjuvants market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Aluminum Adjuvant Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biological Vaccines Adjuvants include GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health Corporation and Associated British Foods, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biological Vaccines Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Vaccines Adjuvants Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, by Type, 2022 (%)
Aluminum Adjuvant
Emulsions Adjuvant
Others
Global Biological Vaccines Adjuvants Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, by Application, 2022 (%)
Human Vaccine
Veterinary Vaccine
Global Biological Vaccines Adjuvants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biological Vaccines Adjuvants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biological Vaccines Adjuvants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biological Vaccines Adjuvants revenues share in global market, 2022 (%)
Key companies Biological Vaccines Adjuvants sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biological Vaccines Adjuvants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health Corporation
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
Vertellus
Allergy Therapeutics
Riboxx GmbH
CaPtivat? Pharmaceuticals
EuBiologics
Pacific GeneTech
Hawaii Biotech
Vaxine Pty Ltd.
Creative Diagnostics
LiteVax BV
Mukta Industries
Oncovir
TiterMax USA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Vaccines Adjuvants, market overview.
Chapter 2: Global Biological Vaccines Adjuvants market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Vaccines Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Vaccines Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Vaccines Adjuvants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biological Vaccines Adjuvants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Vaccines Adjuvants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Vaccines Adjuvants Overall Market Size
2.1 Global Biological Vaccines Adjuvants Market Size: 2022 VS 2029
2.2 Global Biological Vaccines Adjuvants Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biological Vaccines Adjuvants Sales: 2018-2029
3 Company Landscape
3.1 Top Biological Vaccines Adjuvants Players in Global Market
3.2 Top Global Biological Vaccines Adjuvants Companies Ranked by Revenue
3.3 Global Biological Vaccines Adjuvants Revenue by Companies
3.4 Global Biological Vaccines Adjuvants Sales by Companies
3.5 Global Biological Vaccines Adjuvants Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biological Vaccines Adjuvants Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biological Vaccines Adjuvants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biological Vaccines Adjuvants Players in Global Market
3.8.1 List of Global Tier 1 Biological Vaccines Adjuvants Companies
3.8.2 List of Global Tier 2 and Tier 3 Biological Vaccines Adjuvants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biological Vaccines Adjuvants Market Size Markets, 2022 & 2029
4.1.2 Aluminum Adjuvant
4.1.3 Emulsions Adjuvant
4.1.4 Others
4.2 By Type - Global Biological Vaccines Adjuvants Revenue & Forecasts
4.2.1 By Type - Global Biological Vaccines Adjuvants Revenue, 2018-2023
4.2.2 By Type - Global Biological Vaccines Adjuvants Revenue, 2024-2029
4.2.3 By Type - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
4.3 By Type - Global Biological Vaccines Adjuvants Sales & Forecasts
4.3.1 By Type - Global Biological Vaccines Adjuvants Sales, 2018-2023
4.3.2 By Type - Global Biological Vaccines Adjuvants Sales, 2024-2029
4.3.3 By Type - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
4.4 By Type - Global Biological Vaccines Adjuvants Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biological Vaccines Adjuvants Market Size, 2022 & 2029
5.1.2 Human Vaccine
5.1.3 Veterinary Vaccine
5.2 By Application - Global Biological Vaccines Adjuvants Revenue & Forecasts
5.2.1 By Application - Global Biological Vaccines Adjuvants Revenue, 2018-2023
5.2.2 By Application - Global Biological Vaccines Adjuvants Revenue, 2024-2029
5.2.3 By Application - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
5.3 By Application - Global Biological Vaccines Adjuvants Sales & Forecasts
5.3.1 By Application - Global Biological Vaccines Adjuvants Sales, 2018-2023
5.3.2 By Application - Global Biological Vaccines Adjuvants Sales, 2024-2029
5.3.3 By Application - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
5.4 By Application - Global Biological Vaccines Adjuvants Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biological Vaccines Adjuvants Market Size, 2022 & 2029
6.2 By Region - Global Biological Vaccines Adjuvants Revenue & Forecasts
6.2.1 By Region - Global Biological Vaccines Adjuvants Revenue, 2018-2023
6.2.2 By Region - Global Biological Vaccines Adjuvants Revenue, 2024-2029
6.2.3 By Region - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
6.3 By Region - Global Biological Vaccines Adjuvants Sales & Forecasts
6.3.1 By Region - Global Biological Vaccines Adjuvants Sales, 2018-2023
6.3.2 By Region - Global Biological Vaccines Adjuvants Sales, 2024-2029
6.3.3 By Region - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biological Vaccines Adjuvants Revenue, 2018-2029
6.4.2 By Country - North America Biological Vaccines Adjuvants Sales, 2018-2029
6.4.3 US Biological Vaccines Adjuvants Market Size, 2018-2029
6.4.4 Canada Biological Vaccines Adjuvants Market Size, 2018-2029
6.4.5 Mexico Biological Vaccines Adjuvants Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biological Vaccines Adjuvants Revenue, 2018-2029
6.5.2 By Country - Europe Biological Vaccines Adjuvants Sales, 2018-2029
6.5.3 Germany Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.4 France Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.5 U.K. Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.6 Italy Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.7 Russia Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.8 Nordic Countries Biological Vaccines Adjuvants Market Size, 2018-2029
6.5.9 Benelux Biological Vaccines Adjuvants Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biological Vaccines Adjuvants Revenue, 2018-2029
6.6.2 By Region - Asia Biological Vaccines Adjuvants Sales, 2018-2029
6.6.3 China Biological Vaccines Adjuvants Market Size, 2018-2029
6.6.4 Japan Biological Vaccines Adjuvants Market Size, 2018-2029
6.6.5 South Korea Biological Vaccines Adjuvants Market Size, 2018-2029
6.6.6 Southeast Asia Biological Vaccines Adjuvants Market Size, 2018-2029
6.6.7 India Biological Vaccines Adjuvants Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biological Vaccines Adjuvants Revenue, 2018-2029
6.7.2 By Country - South America Biological Vaccines Adjuvants Sales, 2018-2029
6.7.3 Brazil Biological Vaccines Adjuvants Market Size, 2018-2029
6.7.4 Argentina Biological Vaccines Adjuvants Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biological Vaccines Adjuvants Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biological Vaccines Adjuvants Sales, 2018-2029
6.8.3 Turkey Biological Vaccines Adjuvants Market Size, 2018-2029
6.8.4 Israel Biological Vaccines Adjuvants Market Size, 2018-2029
6.8.5 Saudi Arabia Biological Vaccines Adjuvants Market Size, 2018-2029
6.8.6 UAE Biological Vaccines Adjuvants Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Biological Vaccines Adjuvants Major Product Offerings
7.1.4 GSK Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Dynavax Technologies
7.2.1 Dynavax Technologies Company Summary
7.2.2 Dynavax Technologies Business Overview
7.2.3 Dynavax Technologies Biological Vaccines Adjuvants Major Product Offerings
7.2.4 Dynavax Technologies Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.2.5 Dynavax Technologies Key News & Latest Developments
7.3 Novavax
7.3.1 Novavax Company Summary
7.3.2 Novavax Business Overview
7.3.3 Novavax Biological Vaccines Adjuvants Major Product Offerings
7.3.4 Novavax Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.3.5 Novavax Key News & Latest Developments
7.4 Agenus
7.4.1 Agenus Company Summary
7.4.2 Agenus Business Overview
7.4.3 Agenus Biological Vaccines Adjuvants Major Product Offerings
7.4.4 Agenus Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.4.5 Agenus Key News & Latest Developments
7.5 Croda International
7.5.1 Croda International Company Summary
7.5.2 Croda International Business Overview
7.5.3 Croda International Biological Vaccines Adjuvants Major Product Offerings
7.5.4 Croda International Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.5.5 Croda International Key News & Latest Developments
7.6 Seppic
7.6.1 Seppic Company Summary
7.6.2 Seppic Business Overview
7.6.3 Seppic Biological Vaccines Adjuvants Major Product Offerings
7.6.4 Seppic Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.6.5 Seppic Key News & Latest Developments
7.7 OZ Biosciences
7.7.1 OZ Biosciences Company Summary
7.7.2 OZ Biosciences Business Overview
7.7.3 OZ Biosciences Biological Vaccines Adjuvants Major Product Offerings
7.7.4 OZ Biosciences Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.7.5 OZ Biosciences Key News & Latest Developments
7.8 Phibro Animal Health Corporation
7.8.1 Phibro Animal Health Corporation Company Summary
7.8.2 Phibro Animal Health Corporation Business Overview
7.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Major Product Offerings
7.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.8.5 Phibro Animal Health Corporation Key News & Latest Developments
7.9 Associated British Foods
7.9.1 Associated British Foods Company Summary
7.9.2 Associated British Foods Business Overview
7.9.3 Associated British Foods Biological Vaccines Adjuvants Major Product Offerings
7.9.4 Associated British Foods Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.9.5 Associated British Foods Key News & Latest Developments
7.10 InvivoGen
7.10.1 InvivoGen Company Summary
7.10.2 InvivoGen Business Overview
7.10.3 InvivoGen Biological Vaccines Adjuvants Major Product Offerings
7.10.4 InvivoGen Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.10.5 InvivoGen Key News & Latest Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Company Summary
7.11.2 Merck KGaA Biological Vaccines Adjuvants Business Overview
7.11.3 Merck KGaA Biological Vaccines Adjuvants Major Product Offerings
7.11.4 Merck KGaA Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.11.5 Merck KGaA Key News & Latest Developments
7.12 CSL Limited
7.12.1 CSL Limited Company Summary
7.12.2 CSL Limited Biological Vaccines Adjuvants Business Overview
7.12.3 CSL Limited Biological Vaccines Adjuvants Major Product Offerings
7.12.4 CSL Limited Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.12.5 CSL Limited Key News & Latest Developments
7.13 Vertellus
7.13.1 Vertellus Company Summary
7.13.2 Vertellus Biological Vaccines Adjuvants Business Overview
7.13.3 Vertellus Biological Vaccines Adjuvants Major Product Offerings
7.13.4 Vertellus Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.13.5 Vertellus Key News & Latest Developments
7.14 Allergy Therapeutics
7.14.1 Allergy Therapeutics Company Summary
7.14.2 Allergy Therapeutics Business Overview
7.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Major Product Offerings
7.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.14.5 Allergy Therapeutics Key News & Latest Developments
7.15 Riboxx GmbH
7.15.1 Riboxx GmbH Company Summary
7.15.2 Riboxx GmbH Business Overview
7.15.3 Riboxx GmbH Biological Vaccines Adjuvants Major Product Offerings
7.15.4 Riboxx GmbH Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.15.5 Riboxx GmbH Key News & Latest Developments
7.16 CaPtivat? Pharmaceuticals
7.16.1 CaPtivat? Pharmaceuticals Company Summary
7.16.2 CaPtivat? Pharmaceuticals Business Overview
7.16.3 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Major Product Offerings
7.16.4 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.16.5 CaPtivat? Pharmaceuticals Key News & Latest Developments
7.17 EuBiologics
7.17.1 EuBiologics Company Summary
7.17.2 EuBiologics Business Overview
7.17.3 EuBiologics Biological Vaccines Adjuvants Major Product Offerings
7.17.4 EuBiologics Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.17.5 EuBiologics Key News & Latest Developments
7.18 Pacific GeneTech
7.18.1 Pacific GeneTech Company Summary
7.18.2 Pacific GeneTech Business Overview
7.18.3 Pacific GeneTech Biological Vaccines Adjuvants Major Product Offerings
7.18.4 Pacific GeneTech Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.18.5 Pacific GeneTech Key News & Latest Developments
7.19 Hawaii Biotech
7.19.1 Hawaii Biotech Company Summary
7.19.2 Hawaii Biotech Business Overview
7.19.3 Hawaii Biotech Biological Vaccines Adjuvants Major Product Offerings
7.19.4 Hawaii Biotech Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.19.5 Hawaii Biotech Key News & Latest Developments
7.20 Vaxine Pty Ltd.
7.20.1 Vaxine Pty Ltd. Company Summary
7.20.2 Vaxine Pty Ltd. Business Overview
7.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Major Product Offerings
7.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.20.5 Vaxine Pty Ltd. Key News & Latest Developments
7.21 Creative Diagnostics
7.21.1 Creative Diagnostics Company Summary
7.21.2 Creative Diagnostics Business Overview
7.21.3 Creative Diagnostics Biological Vaccines Adjuvants Major Product Offerings
7.21.4 Creative Diagnostics Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.21.5 Creative Diagnostics Key News & Latest Developments
7.22 LiteVax BV
7.22.1 LiteVax BV Company Summary
7.22.2 LiteVax BV Business Overview
7.22.3 LiteVax BV Biological Vaccines Adjuvants Major Product Offerings
7.22.4 LiteVax BV Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.22.5 LiteVax BV Key News & Latest Developments
7.23 Mukta Industries
7.23.1 Mukta Industries Company Summary
7.23.2 Mukta Industries Business Overview
7.23.3 Mukta Industries Biological Vaccines Adjuvants Major Product Offerings
7.23.4 Mukta Industries Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.23.5 Mukta Industries Key News & Latest Developments
7.24 Oncovir
7.24.1 Oncovir Company Summary
7.24.2 Oncovir Business Overview
7.24.3 Oncovir Biological Vaccines Adjuvants Major Product Offerings
7.24.4 Oncovir Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.24.5 Oncovir Key News & Latest Developments
7.25 TiterMax USA
7.25.1 TiterMax USA Company Summary
7.25.2 TiterMax USA Business Overview
7.25.3 TiterMax USA Biological Vaccines Adjuvants Major Product Offerings
7.25.4 TiterMax USA Biological Vaccines Adjuvants Sales and Revenue in Global (2018-2023)
7.25.5 TiterMax USA Key News & Latest Developments
8 Global Biological Vaccines Adjuvants Production Capacity, Analysis
8.1 Global Biological Vaccines Adjuvants Production Capacity, 2018-2029
8.2 Biological Vaccines Adjuvants Production Capacity of Key Manufacturers in Global Market
8.3 Global Biological Vaccines Adjuvants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biological Vaccines Adjuvants Supply Chain Analysis
10.1 Biological Vaccines Adjuvants Industry Value Chain
10.2 Biological Vaccines Adjuvants Upstream Market
10.3 Biological Vaccines Adjuvants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biological Vaccines Adjuvants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biological Vaccines Adjuvants in Global Market
Table 2. Top Biological Vaccines Adjuvants Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biological Vaccines Adjuvants Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biological Vaccines Adjuvants Revenue Share by Companies, 2018-2023
Table 5. Global Biological Vaccines Adjuvants Sales by Companies, (K Units), 2018-2023
Table 6. Global Biological Vaccines Adjuvants Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biological Vaccines Adjuvants Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Biological Vaccines Adjuvants Product Type
Table 9. List of Global Tier 1 Biological Vaccines Adjuvants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biological Vaccines Adjuvants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biological Vaccines Adjuvants Sales (K Units), 2018-2023
Table 15. By Type - Global Biological Vaccines Adjuvants Sales (K Units), 2024-2029
Table 16. By Application ? Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biological Vaccines Adjuvants Sales (K Units), 2018-2023
Table 20. By Application - Global Biological Vaccines Adjuvants Sales (K Units), 2024-2029
Table 21. By Region ? Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biological Vaccines Adjuvants Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biological Vaccines Adjuvants Sales (K Units), 2018-2023
Table 25. By Region - Global Biological Vaccines Adjuvants Sales (K Units), 2024-2029
Table 26. By Country - North America Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biological Vaccines Adjuvants Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biological Vaccines Adjuvants Sales, (K Units), 2018-2023
Table 29. By Country - North America Biological Vaccines Adjuvants Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biological Vaccines Adjuvants Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biological Vaccines Adjuvants Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biological Vaccines Adjuvants Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biological Vaccines Adjuvants Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biological Vaccines Adjuvants Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biological Vaccines Adjuvants Sales, (K Units), 2024-2029
Table 38. By Country - South America Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biological Vaccines Adjuvants Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biological Vaccines Adjuvants Sales, (K Units), 2018-2023
Table 41. By Country - South America Biological Vaccines Adjuvants Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biological Vaccines Adjuvants Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biological Vaccines Adjuvants Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biological Vaccines Adjuvants Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Biological Vaccines Adjuvants Product Offerings
Table 48. GSK Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Dynavax Technologies Company Summary
Table 51. Dynavax Technologies Biological Vaccines Adjuvants Product Offerings
Table 52. Dynavax Technologies Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Dynavax Technologies Key News & Latest Developments
Table 54. Novavax Company Summary
Table 55. Novavax Biological Vaccines Adjuvants Product Offerings
Table 56. Novavax Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Novavax Key News & Latest Developments
Table 58. Agenus Company Summary
Table 59. Agenus Biological Vaccines Adjuvants Product Offerings
Table 60. Agenus Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Agenus Key News & Latest Developments
Table 62. Croda International Company Summary
Table 63. Croda International Biological Vaccines Adjuvants Product Offerings
Table 64. Croda International Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Croda International Key News & Latest Developments
Table 66. Seppic Company Summary
Table 67. Seppic Biological Vaccines Adjuvants Product Offerings
Table 68. Seppic Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Seppic Key News & Latest Developments
Table 70. OZ Biosciences Company Summary
Table 71. OZ Biosciences Biological Vaccines Adjuvants Product Offerings
Table 72. OZ Biosciences Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. OZ Biosciences Key News & Latest Developments
Table 74. Phibro Animal Health Corporation Company Summary
Table 75. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product Offerings
Table 76. Phibro Animal Health Corporation Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Phibro Animal Health Corporation Key News & Latest Developments
Table 78. Associated British Foods Company Summary
Table 79. Associated British Foods Biological Vaccines Adjuvants Product Offerings
Table 80. Associated British Foods Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Associated British Foods Key News & Latest Developments
Table 82. InvivoGen Company Summary
Table 83. InvivoGen Biological Vaccines Adjuvants Product Offerings
Table 84. InvivoGen Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. InvivoGen Key News & Latest Developments
Table 86. Merck KGaA Company Summary
Table 87. Merck KGaA Biological Vaccines Adjuvants Product Offerings
Table 88. Merck KGaA Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Merck KGaA Key News & Latest Developments
Table 90. CSL Limited Company Summary
Table 91. CSL Limited Biological Vaccines Adjuvants Product Offerings
Table 92. CSL Limited Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. CSL Limited Key News & Latest Developments
Table 94. Vertellus Company Summary
Table 95. Vertellus Biological Vaccines Adjuvants Product Offerings
Table 96. Vertellus Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Vertellus Key News & Latest Developments
Table 98. Allergy Therapeutics Company Summary
Table 99. Allergy Therapeutics Biological Vaccines Adjuvants Product Offerings
Table 100. Allergy Therapeutics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Allergy Therapeutics Key News & Latest Developments
Table 102. Riboxx GmbH Company Summary
Table 103. Riboxx GmbH Biological Vaccines Adjuvants Product Offerings
Table 104. Riboxx GmbH Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Riboxx GmbH Key News & Latest Developments
Table 106. CaPtivat? Pharmaceuticals Company Summary
Table 107. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product Offerings
Table 108. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. CaPtivat? Pharmaceuticals Key News & Latest Developments
Table 110. EuBiologics Company Summary
Table 111. EuBiologics Biological Vaccines Adjuvants Product Offerings
Table 112. EuBiologics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. EuBiologics Key News & Latest Developments
Table 114. Pacific GeneTech Company Summary
Table 115. Pacific GeneTech Biological Vaccines Adjuvants Product Offerings
Table 116. Pacific GeneTech Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Pacific GeneTech Key News & Latest Developments
Table 118. Hawaii Biotech Company Summary
Table 119. Hawaii Biotech Biological Vaccines Adjuvants Product Offerings
Table 120. Hawaii Biotech Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Hawaii Biotech Key News & Latest Developments
Table 122. Vaxine Pty Ltd. Company Summary
Table 123. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product Offerings
Table 124. Vaxine Pty Ltd. Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Vaxine Pty Ltd. Key News & Latest Developments
Table 126. Creative Diagnostics Company Summary
Table 127. Creative Diagnostics Biological Vaccines Adjuvants Product Offerings
Table 128. Creative Diagnostics Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Creative Diagnostics Key News & Latest Developments
Table 130. LiteVax BV Company Summary
Table 131. LiteVax BV Biological Vaccines Adjuvants Product Offerings
Table 132. LiteVax BV Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. LiteVax BV Key News & Latest Developments
Table 134. Mukta Industries Company Summary
Table 135. Mukta Industries Biological Vaccines Adjuvants Product Offerings
Table 136. Mukta Industries Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 137. Mukta Industries Key News & Latest Developments
Table 138. Oncovir Company Summary
Table 139. Oncovir Biological Vaccines Adjuvants Product Offerings
Table 140. Oncovir Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 141. Oncovir Key News & Latest Developments
Table 142. TiterMax USA Company Summary
Table 143. TiterMax USA Biological Vaccines Adjuvants Product Offerings
Table 144. TiterMax USA Biological Vaccines Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 145. TiterMax USA Key News & Latest Developments
Table 146. Biological Vaccines Adjuvants Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 147. Global Biological Vaccines Adjuvants Capacity Market Share of Key Manufacturers, 2021-2023
Table 148. Global Biological Vaccines Adjuvants Production by Region, 2018-2023 (K Units)
Table 149. Global Biological Vaccines Adjuvants Production by Region, 2024-2029 (K Units)
Table 150. Biological Vaccines Adjuvants Market Opportunities & Trends in Global Market
Table 151. Biological Vaccines Adjuvants Market Drivers in Global Market
Table 152. Biological Vaccines Adjuvants Market Restraints in Global Market
Table 153. Biological Vaccines Adjuvants Raw Materials
Table 154. Biological Vaccines Adjuvants Raw Materials Suppliers in Global Market
Table 155. Typical Biological Vaccines Adjuvants Downstream
Table 156. Biological Vaccines Adjuvants Downstream Clients in Global Market
Table 157. Biological Vaccines Adjuvants Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biological Vaccines Adjuvants Segment by Type in 2022
Figure 2. Biological Vaccines Adjuvants Segment by Application in 2022
Figure 3. Global Biological Vaccines Adjuvants Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biological Vaccines Adjuvants Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biological Vaccines Adjuvants Revenue, 2018-2029 (US$, Mn)
Figure 7. Biological Vaccines Adjuvants Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biological Vaccines Adjuvants Revenue in 2022
Figure 9. By Type - Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 12. By Type - Global Biological Vaccines Adjuvants Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 16. By Application - Global Biological Vaccines Adjuvants Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Biological Vaccines Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biological Vaccines Adjuvants Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 21. By Country - North America Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 23. US Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 28. Germany Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 29. France Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 37. China Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 41. India Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 44. Brazil Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biological Vaccines Adjuvants Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biological Vaccines Adjuvants Sales Market Share, 2018-2029
Figure 48. Turkey Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biological Vaccines Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biological Vaccines Adjuvants Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biological Vaccines Adjuvants by Region, 2022 VS 2029
Figure 54. Biological Vaccines Adjuvants Industry Value Chain
Figure 55. Marketing Channels
